Old Mission Capital’s Instil Bio TIL Stock Holding History

Old Mission Capital’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-792	Closed	-$8.73K	–	1566
2023 Q2	$8.73K	Buy	+792	New	+$9.68K	﹤0.01%	1252

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Old Mission Capital's TIL Position: Q3 2023 in Review

Old Mission Capital sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 792 shares — an estimated $8.73K sold.

Old Mission Capital first reported a position in TIL in Q2 2023 and held it in 1 quarter. The position peaked at $8.73K in Q2 2023. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

Old Mission Capital reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
Old Mission Capital sold 792 Instil Bio shares in Q3 2023, an estimated $8.73K.
Old Mission Capital first reported a position in Instil Bio in Q2 2023 and held it in 1 quarter.
Old Mission Capital's Instil Bio position peaked at $8.73K in Q2 2023.
58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.